PROGRESS - Perindopril Protection Against Recurrent Stroke Study: Characteristics of the study population at baseline

Journal of Hypertension

Volumn 17, Issue 11, 1999, Pages 1647-1655

  Chalmers, J ^a   MacMahon, S ^a   Bousser, M G ^a   Cutler, J ^a   Donnan, G ^a   Hansson, L ^a   Harrap, S ^a   Liu, L ^a   Mancia, G ^a   Omae, T ^a   Reid, J ^a   Rodgers, A ^a   Warlow, C ^a  

^a NONE

Author keywords

Angiotensin converting enzyme inhibitors; Cardiovascular events; Cerebrovascular disease; Cognitive function; Dementia; Hypertension; Indapamide; Perindopril; Randomized controlled trial; Stroke

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDAPAMIDE; PERINDOPRIL;

ADULT; ARTICLE; AUSTRALIA; BELGIUM; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DRUG CONTRAINDICATION; FEMALE; FOLLOW UP; FRANCE; HUMAN; IRELAND; ITALY; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEW ZEALAND; ORAL DRUG ADMINISTRATION; PHYSICAL DISABILITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; STROKE; SWEDEN; TRANSIENT ISCHEMIC ATTACK; UNITED KINGDOM;

EID: 0032737202     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. PROGRESS Management Committee. Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS, J Hypertens 1996; 14 (Suppl. 2):S41-S46.
2. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J et al. Blood pressure, stroke, and coronary heart disease. Part I, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
3. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13000 strokes in 45000 people in 45 prospective cohorts, Lancet 1995; 346:1647-1653.
4. Omae T, Ueda K. Hypertension and cerebrovascular disease-the Japanese experience. J Hypertens 1988; 6:343-349.
5. Eastern Stroke and Coronary Heart Disease Collaborative Research Group, Blood pressure, cholesterol and stroke in eastern Asia. Lancet 1998; 352:1801-1807.
6. UKTIA Study Group. The United Kingdom transient ischaemic attack (UK-TlA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991; 54;1044-1054.
7. Collins R, Peto R, MacMahon S, Herbert P, Fiebach NH, Eberlein KA et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827-839.
8. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994; 50:272-298.
9. Carter AB. Hypotensive therapy in stroke survivors. Lancet 1970; 1(7345):485-9.
10. Hypertension Stroke Cooperative Study Group. Effect of antihypertensive treatment on stroke recurrence. J Am Med Assoc 1974; 229:409-418.
11. Dutch TIATSG. Trial of secondary prevention with atenotol after transient ischaemic attack or non-disabling ischaemic stroke. Stroke 1993; 24:543-548.
12. Eriksson S, Olofsson B-O, Wester P-O, Atenolol in secondary prevention after stroke. Cerebrovasc Diseases 1995; 5:21-25.
13. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators, Effect of antihypertensive treatment in patients having already suffered from stroke; gathering the evidence, Stroke 1997; 28:2557-2562.
14. Neal B, Anderson C, Chalmers J, MacMahon S, Rodgers A. Blood pressure lowering in patients with cerebrovascular disease: results of the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) pilot phase. Clin Exp Pharmacol Physiology 1996; 23:444-446.
15. PROGRESS (Perindopril protection against recurrent stroke study) Management Committee, PROGRESS-Perindopril protection against recurrent stroke study: status in July 1996. J Hypertens 1996; 14 (Suppl. 6):S49-S51.
16. Lindley RI, Waddell F, Livingstone M, Sandercock P, Dennis MS, Slattery J, et al. Can simple questions assess outcome after stroke? Cerebrovas Diseases 1994; 4:314-324.
17. The American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington DC: American Psychiatric Association; 1994.
18. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. MD State Med J 1965; 14 (2):61-65.
19. Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J, et al. Multiprovincial monitoring of the trends and determinants in cardiovascular diseases (Sino-Monica project)-I, Morbidity and mortality monitoring. Chin J Cardiol 1997; 25 (1):6-11.